More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor

More Evidence for Non-P2Y₁₂-Mediated Effects of Ticagrelor

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1659-1661. doi: 10.1016/j.jcin.2017.06.014.

¹ Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, Virginia.
² Department of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.
³ Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: paul.gurbel@inova.org.

No abstract available

Keywords: acute coronary syndrome(s); non-P2Y(12)-mediated effects; ticagrelor.